Our team can walk you through current availability, bulk pricing, and storage details so you can place an informed order
TB-500 studies examine epicardial progenitor cell mobilization and neovascularization processes
Research Dose Ranges Preclinical animal studies: 110 mcg/kg (nanogram to microgram range) once or twice daily Extrapolated human equivalent range commonly discussed in clinical literature: 200500 mcg/day Human pilot IV data: doses up to 20 mg were tolerated without adverse effects in two healthy adults (Lee & Burgess, 2025) though this is far above typical outpatient dosing Protocol: Musculoskeletal / Connective Tissue Healing For tendon, ligament, or muscle injury recovery, the standard approach in clinical functional medicine practice involves: SubQ injection at 200500 mcg once daily , injected near (not into) the injury site Cycle length: typically 48 weeks , with reassessment Often combined with TB-500 (thymosin beta-4) for synergistic tissue remodeling the BPC+TB stack Best results seen alongside physical therapy, not as a substitute for it Protocol: Gut and GI Mucosal Healing For IBD, gut permeability, NSAID damage, or H
Does not interfere with insulin sensitivity, making it potentially safer for individuals at risk of diabetes or metabolic disorders
Never disappoints Bridget Short Hills, NJ Evolve is the ultimate experience
Tissue Healing and Repair BPC 157 is most well-known for its proposed tissue healing properties, including tendons, ligaments, muscles, and bones, by the following mechanisms: Impacting growth factors: It may activate the JAK2 signaling pathway and increase growth hormone receptor activity, particularly in tendon cells, enhancing their ability to respond to growth hormone
